Literature DB >> 19834718

Comparison of mild stimulation and conventional stimulation in ART outcome.

Mohammad Ali Karimzadeh1, Shahnaz Ahmadi, Homa Oskouian, Elham Rahmani.   

Abstract

PURPOSE: To provide a treatment for particular condition that is the most effective treatment with the least risk and cost for the patient we compared the efficacy of using clomiphene 100 mg + delayed low dose gonadotropin + flexible GnRH antagonist administration for ovarian stimulation protocol and GnRH agonist + gonadotropin for stimulation protocol in IVF outcome.
METHODS: Clinical outcome of 243 women with regularly menstruation who were candidate for IVF. They had undergone stimulation with GnRH agonist and gonadotropin (group A) or clomiphene citrate, gonadotropin and GnRH antagonist (group B). Main outcome was ongoing pregnancy.
RESULTS: There were no significant difference in mean age, cause of infertility, basal FSH, BMI, duration of infertility, endometrial thickness on the day HCG administration in two groups. The number of recovered oocytes, obtained embryos, transferred embryos, peak of estradiol on the day HCG administration and OHSS were significantly higher in group A. Significantly more patients in control group had embryos for cryopreservation. There were no significant difference in clinical pregnancy rate and ongoing pregnancy rate between two groups.
CONCLUSION: Clomiphene + delayed low dose gonadotropin + flexible GnRH - antagonist stimulation is an acceptable alternative protocol for IVF in patients with regularly menstruation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19834718     DOI: 10.1007/s00404-009-1252-4

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  11 in total

1.  Controlled Ovarian Stimulation Protocols Alter Endometrial Histomorphology and Gene Expression Profiles.

Authors:  John L Wu; Patrick Keller; Mohammed Kanchwala; Chao Xing; Samir N Babayev; Bruce R Carr; Orhan Bukulmez; R Ann Word
Journal:  Reprod Sci       Date:  2020-01-06       Impact factor: 3.060

Review 2.  Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization.

Authors:  Alberto Revelli; Simona Casano; Francesca Salvagno; Luisa Delle Piane
Journal:  Reprod Biol Endocrinol       Date:  2011-02-16       Impact factor: 5.211

Review 3.  Prevention of Ovarian Hyperstimulation Syndrome: A Review.

Authors:  Vinayak Smith; Tiki Osianlis; Beverley Vollenhoven
Journal:  Obstet Gynecol Int       Date:  2015-05-14

4.  Comparison of pregnancy outcome after letrozole versus clomiphene treatment for mild ovarian stimulation protocol in poor responders.

Authors:  Maryam Eftekhar; Farnaz Mohammadian; Robab Davar; Soheila Pourmasumi
Journal:  Iran J Reprod Med       Date:  2014-11

5.  Comparison of GnRH agonist, GnRH antagonist, and GnRH antagonist mild protocol of controlled ovarian hyperstimulation in good prognosis patients.

Authors:  Martin Stimpfel; Eda Vrtacnik-Bokal; Barbara Pozlep; Irma Virant-Klun
Journal:  Int J Endocrinol       Date:  2015-03-17       Impact factor: 3.257

6.  Hypertensive Disorders in Pregnant Women Receiving Fertility Treatments.

Authors:  Maryam Barekat; Shahnaz Ahmadi
Journal:  Int J Fertil Steril       Date:  2018-01-07

7.  Use of Clomiphene Citrate in minimal stimulation in vitro fertilization negatively impacts endometrial thickness: an argument for a freeze-all approach.

Authors:  Beverly G Reed; John L Wu; Laurice Bou Nemer; Bruce R Carr; Orhan Bukulmez
Journal:  JBRA Assist Reprod       Date:  2018-11-01

8.  The association of serum estradiol level with outcomes of clomiphene citrate/human menopausal gonadotropin ovarian stimulation for in vitro fertilization and embryo transfer.

Authors:  Xiao-Jin Zhang; Su-Ying Liu; Wei Fu; Xiao-Xi Sun
Journal:  Reprod Biol Endocrinol       Date:  2015-10-06       Impact factor: 5.211

9.  GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial.

Authors:  Usama M Fouda; Ahmed M Sayed; Hesham S Elshaer; Bahaa Eldin M Hammad; Mona M Shaban; Khaled A Elsetohy; Mohamed A Youssef
Journal:  J Ovarian Res       Date:  2016-05-17       Impact factor: 4.234

Review 10.  Recent advances in oncofertility care worldwide and in Japan.

Authors:  Yasushi Takai
Journal:  Reprod Med Biol       Date:  2018-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.